Growth Metrics

Rigel Pharmaceuticals (RIGL) Other Working Capital Changes (2016 - 2025)

Rigel Pharmaceuticals has reported Other Working Capital Changes over the past 16 years, most recently at $11.0 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 363.0% year-over-year to $11.0 million; the TTM value through Dec 2025 reached $11.8 million, up 1812.14%, while the annual FY2025 figure was $11.8 million, 1812.14% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was $11.0 million at Rigel Pharmaceuticals, up from -$81000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $11.0 million in Q4 2025 and troughed at -$6.3 million in Q3 2022.
  • A 5-year average of $9000.0 and a median of -$497500.0 in 2022 define the central range for Other Working Capital Changes.
  • Biggest five-year swings in Other Working Capital Changes: tumbled 695.64% in 2022 and later soared 402.58% in 2024.
  • Year by year, Other Working Capital Changes stood at -$2.2 million in 2021, then skyrocketed by 373.13% to $6.1 million in 2022, then tumbled by 31.24% to $4.2 million in 2023, then tumbled by 199.4% to -$4.2 million in 2024, then skyrocketed by 363.0% to $11.0 million in 2025.
  • Business Quant data shows Other Working Capital Changes for RIGL at $11.0 million in Q4 2025, -$81000.0 in Q3 2025, and -$89000.0 in Q2 2025.